Please login to the form below

Not currently logged in
Email:
Password:

Novimmune

This page shows the latest Novimmune news and features for those working in and with pharma, biotech and healthcare.

Shire strikes bi-specific antibody deal with Novimmune

Shire strikes bi-specific antibody deal with Novimmune

Shire strikes bi-specific antibody deal with Novimmune. Pharma giant obtains licence for haemophilia A candidate. ... Privately-held Swiss biopharmaceutical company Novimmune has entered a deal with Shire, allowing the pharma giant to take reign over its

Latest news

  • TxCell plans listing as EU biotech wakes up to IPOs

    Reuters suggests three other European biotechs - AC Immune, Novimmune and Molecular Partners - are also thinking about going public at the moment, indicating rising confidence among the investment community about the prospects

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Sosei appoints CFO Sosei appoints CFO

    Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

  • Novimmune appoints Guillaume de Sampaïo Novimmune appoints Guillaume de Sampaïo

    Novimmune appoints Guillaume de Sampaïo. He brings experience from Roche, Novartis and Actelion to the Swiss biotech . ... Prior to joining Novimmune he served at Danish biotech firm Forward Pharma, where he created and managed its clinical development

  • Novimmune expands senior management team Novimmune expands senior management team

    Novimmune expands senior management team. Dr Sven Zimmerman and Mylène Fleurant join the Swiss biotech. ... Eduard Holdener, chairman and chief executive of Novimmune, said: “ We continue to add capabilities to our strong and experienced management

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics